Back to Results
First PageMeta Content
Protease inhibitors / Medicine / Organofluorides / Pyridines / Purines / Antiretroviral drug / Darunavir / Tipranavir / Reverse-transcriptase inhibitor / Chemistry / Organic chemistry / HIV/AIDS


New Developments in HIV Drug Resistance and Options for Treatment-Experienced Patients - The Body
Add to Reading List

Document Date: 2007-05-23 11:02:00

Open Document

File Size: 397,30 KB

Share Result on Facebook

Company

ABC / Monogram Biosciences / /

Country

Switzerland / France / United States / Italy / United Kingdom / Spain / Monaco / /

IndustryTerm

revised tipranavir genotype algorithm / genotypic resistance algorithms / several HIV treatment / /

MedicalCondition

HIV infection / advanced disease / HIV / Opportunistic Infections / HIV RNA / HIV genotype / cut / hepatitis B/C / /

MedicalTreatment

salvage therapy / antiretroviral therapy / HAART / /

Organization

U.S. Food and Drug Administration / Stanford University / National Agency for AIDS Research / British HIV Association / U.S. Centers for Disease Control and Prevention / /

Person

Ada Bertoli / Joseph Llibre / Dominique Costagliola / Eoin Coakley / Cal Cohen / Bonaventura Clotet / Jonathan M. Schapiro / /

Position

RT / HIV RT / /

Product

Aptivus / Videx / Fuzeon / Norvir / abacavir / Viread / HIV Drug / didanosine / Ziagen / Reyataz / /

RadioStation

1 With / /

Technology

genotypic resistance algorithms / Genotype / revised tipranavir genotype algorithm / /

URL

TheBody.com / www.thebody.com/content/art1354.html / http /

SocialTag